Skip to main content

Table 2 Characteristics of patients with and without cardiovascular drugs, Swedish Dementia Registry 2007 to 2012

From: Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry

 

CV medication (n= 13,847)

Without CV medication (n= 5,896)

P value

Age

   

 Mean

79.6 ± 7.2

77.4 ± 8.9

<0.001

 Range

33 to 103

27 to 97

Gender

   

 Female (%)

55.9

64.4

<0.001

 Male (%)

44.1

35.6

MMSE

   

 Mean

21.4 ± 4.9

21.3 ± 5.2

<0.001

 Range

0 to 30

0 to 30

Living alone (%)

43.7

45.7

0.006

ChEIs (%)

46.1

58.5

<0.001

NMDA antagonists (%)

10.6

10.3

0.028

Number of drugs

   

 Mean

5.8 ± 3

3,0 ± 2.5

<0.001

 Range

0 to 24

0 to 21

AD (%)

34.9

56.0

<0.001

MixD (%)

28.9

20.4

<0.001

VaD (%)

30.3

13.2

<0.001

DLB (%)

2.6

4.2

<0.001

FTD (%)

1.6

3.2

<0.001

PDD (%)

1.7

2.9

<0.001

  1. AD, Alzheimer’s disease; ChEI, cholinesterase inhibitor; CV, cardiovascular; DLB, dementia with Lewy bodies; FTD, frontotemporal dementia; MixD, mixed dementia; MMSE, Mini Mental State Examination; NMDA, N-methyl-d-aspartate; PDD, Parkinson’s disease dementia; VaD, vascular dementia.
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193